The Development of CK2 Inhibitors: From Traditional Pharmacology to in Silico Rational Drug Design.
about
An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2.In Silico Screening and In Vitro Activity Measurement of Javamide Analogues as Potential p38 MAPK Inhibitors.Self-Assembled Supramolecular Nanoparticles Improve the Cytotoxic Efficacy of CK2 Inhibitor THN7.Phosphorylation of xeroderma pigmentosum group C regulates ultraviolet-induced DNA damage repair.
P2860
The Development of CK2 Inhibitors: From Traditional Pharmacology to in Silico Rational Drug Design.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
The Development of CK2 Inhibit ...... n Silico Rational Drug Design.
@ast
The Development of CK2 Inhibit ...... n Silico Rational Drug Design.
@en
type
label
The Development of CK2 Inhibit ...... n Silico Rational Drug Design.
@ast
The Development of CK2 Inhibit ...... n Silico Rational Drug Design.
@en
prefLabel
The Development of CK2 Inhibit ...... n Silico Rational Drug Design.
@ast
The Development of CK2 Inhibit ...... n Silico Rational Drug Design.
@en
P2860
P356
P1433
P1476
The Development of CK2 Inhibit ...... n Silico Rational Drug Design.
@en
P2093
Giorgio Cozza
P2860
P356
10.3390/PH10010026
P577
2017-02-20T00:00:00Z